Correlation Between Axim Biotechnologies and Regenicin
Can any of the company-specific risk be diversified away by investing in both Axim Biotechnologies and Regenicin at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axim Biotechnologies and Regenicin into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axim Biotechnologies and Regenicin, you can compare the effects of market volatilities on Axim Biotechnologies and Regenicin and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axim Biotechnologies with a short position of Regenicin. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axim Biotechnologies and Regenicin.
Diversification Opportunities for Axim Biotechnologies and Regenicin
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Axim and Regenicin is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Axim Biotechnologies and Regenicin in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regenicin and Axim Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axim Biotechnologies are associated (or correlated) with Regenicin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regenicin has no effect on the direction of Axim Biotechnologies i.e., Axim Biotechnologies and Regenicin go up and down completely randomly.
Pair Corralation between Axim Biotechnologies and Regenicin
If you would invest 0.20 in Axim Biotechnologies on December 28, 2024 and sell it today you would earn a total of 0.10 from holding Axim Biotechnologies or generate 50.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Axim Biotechnologies vs. Regenicin
Performance |
Timeline |
Axim Biotechnologies |
Regenicin |
Axim Biotechnologies and Regenicin Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Axim Biotechnologies and Regenicin
The main advantage of trading using opposite Axim Biotechnologies and Regenicin positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axim Biotechnologies position performs unexpectedly, Regenicin can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regenicin will offset losses from the drop in Regenicin's long position.Axim Biotechnologies vs. Cellectis SA | Axim Biotechnologies vs. Biotron Limited | Axim Biotechnologies vs. Regenicin | Axim Biotechnologies vs. biOasis Technologies |
Regenicin vs. Denali Therapeutics | Regenicin vs. Cardiff Oncology | Regenicin vs. Cytodyn | Regenicin vs. Inovio Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |